Proteo, Inc. (OTCMKTS:PTEO – Get Free Report)’s stock price passed below its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.09 and traded as low as $0.09. Proteo shares last traded at $0.09, with a volume of 0 shares trading hands.
Proteo Price Performance
The firm has a 50 day simple moving average of $0.09 and a 200-day simple moving average of $0.09.
About Proteo
Proteo, Inc, a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The company focuses on the development of pharmaceuticals based on Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands for use in the treatment of post-surgery damage to tissue; complications resulting from organ transplantation; pulmonary hypertension; and injuries caused by accidents, cardiac infarction, and other diseases.
Featured Stories
- Five stocks we like better than Proteo
- Investing in Construction Stocks
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- 3 Tickers Leading a Meme Stock Revival
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Stock Dividend Cuts Happen Are You Ready?
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Proteo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteo and related companies with MarketBeat.com's FREE daily email newsletter.